Advanz Pharma Corp. is a British multinational pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018.[3] The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. The company also focuses on acquiring legacy pharmaceutical compounds which are usually off-patent.[4] The operational headquarters is in London, UK, the operations centre is in Mumbai, India and regional hubs are located in Europe, Australia, and Canada.
History
2013
In May the company acquired pediatric products (Kapvay, Orapred ODT & OS) from Shionogi Inc.[5]